Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising application in regenerative medicine
3.2.1.2 Increase in demand for 3D printed tissue and organs
3.2.1.3 Rise in prevalence of chronic disease and organ failure
3.2.1.4 Advancement in bioprinting technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent approval filing process
3.2.2.2 High manufacturing cost
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future Market trends
3.6 Technological advancements
3.7 GAP analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Natural bioink
5.3 Synthetic bioink
Chapter 6 Market Estimates and Forecast, By Material, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Collagen
6.3 Alginate
6.4 Gelatin
6.5 Agarose
6.6 Chitosan
6.7 Pluronic
6.8 Other materials
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Tissue engineering
7.3 Medical application
7.4 Drug discovery & delivery
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By Printing Modality, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Extrusion based bioprinting
8.3 Ink-jet based bioprinting
8.4 Laser-based bioprinting
Chapter 9 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Pharmaceutical & biotechnology companies
9.3 Academic & research institutes
9.4 Hospitals and clinics
9.5 Other end-users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.1.1 U.S.
10.1.2 Canada
10.2 Europe
10.2.1 Germany
10.2.2 UK
10.2.3 France
10.2.4 Italy
10.2.5 Spain
10.2.6 Netherlands
10.2.7 Rest of Europe
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 Australia
10.3.5 South Korea
10.3.6 Rest of Asia Pacific
10.4 Latin America
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Rest of Latin America
10.5 Middle East and Africa
10.5.1 South Africa
10.5.2 Saudi Arabia
10.5.3 UAE
10.5.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Allevi, Inc. (3D Systems)
11.2 Axolotl Biosciences
11.3 BIO INX
11.4 CELLLINK (BICO)
11.5 CollPlant Biotechnologies Ltd
11.6 Foldink
11.7 Gelomics
11.8 INNOREGEN, Inc.
11.9 Merck KGaA
11.10 Rokit Healthcare
11.11 TheWell Bioscience Inc.
11.12 UPM Biomedicals
11.13 Viscient Biosciences
11.14 VoxCell BioInnovation Inc.
